Morgan Stanley Call 92.5 XS4 21.0.../ DE000MB0MT92 /
2024-05-20 8:29:16 PM | Chg.-0.001 | Bid10:00:32 PM | Ask10:00:32 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.019EUR | -5.00% | - Bid Size: - |
- Ask Size: - |
ON SEMICOND. D... | 92.50 - | 2024-06-21 | Call |
GlobeNewswire
10:20 PM
Kayne Anderson Energy Infrastructure Fund Completes Private Placement of $75 Million of Notes
GlobeNewswire
10:17 PM
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integral Ad Scie...
GlobeNewswire
10:16 PM
Avalyn Presents Clinical Data on AP01 for Pulmonary Fibrosis, Including Long-Term Efficacy and Imagi...
GlobeNewswire
10:15 PM
APA Announces over $700 Million in Asset Sales from Two Transactions for Non-core Texas Properties
GlobeNewswire
10:15 PM
Gaming and Leisure Properties, Inc. Declares Second Quarter 2024 Cash Dividend of $0.76 Per Share
GlobeNewswire
10:14 PM
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XPEL, Inc. - XPE...
GlobeNewswire
10:09 PM
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against UnitedHealth Gr...
GlobeNewswire
10:07 PM
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Intel Corporati...
GlobeNewswire
10:05 PM
Zoom Video Communications Reports Financial Results for the First Quarter of Fiscal Year 2025
GlobeNewswire
10:05 PM
VESTIS CORPORATION (NYSE: VSTS) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities C...
GlobeNewswire
10:05 PM
Reliance Global Group Reports First Quarter 2024 Results and Provides Business Update
GlobeNewswire
10:05 PM
Larimar Therapeutics Announces FDA has Removed Partial Clinical Hold for Nomlabofusp Program in Frie...